Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.What you need to know. Researchers at the Veterans' Affairs ...